Top Medical News from Across Medscape

  • Canakinumab Reduces Gout Risk Without Changing SUA LevelsCanakinumab, an interleukin 1-beta blocker, was associated with significantly lower risk for gout attacks when given quarterly, but did not change serum uric acid levels, a study has found.
  • For Stubborn COPD, Airway Ablation Bolsters Drug EffectsTargeted lung denervation appears to maximize the benefits of the anticholinergic drugs often prescribed to patients with chronic obstructive pulmonary disease (COPD), new research shows.
  • WHO: Global Efforts to End TB 'Off Track'Global efforts have averted an estimated 54 million tuberculosis deaths since 2000, but tuberculosis remains the world's deadliest infectious disease and countries are still not doing enough to end it by 2030, WHO says.

Special Report

Business of Medicine

  • False Cancer Diagnosis Leads to Malpractice Suit; More Patient and his family suffer a 'week of hell'; Fessing up can lower malpractice risks, study says; Is this new law a help or a hindrance?; Sovereign immunity can be extended, panel rules.
  • How Hospital Changes Will Affect Doctors' Practices Hospitals have been swept up in four major trends over the past several years. Which of these are likely to continue, and what form will they take? The answers could affect how you practice.

Medscape Editor-in-Chief

  • Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California